Rice Hall James & Associates’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-72,417
Closed -$18.2M 282
2019
Q2
$18.2M Buy
+72,417
New +$16.8M 0.61% 59
2017
Q2
Sell
-3,713
Closed -$567K 300
2017
Q1
$567K Buy
3,713
+98
+3% +$14.3K 0.03% 260
2016
Q4
$533K Buy
3,615
+613
+20% +$88.7K 0.03% 260
2016
Q3
$379K Buy
3,002
+37
+1% +$4.46K 0.02% 269
2016
Q2
$334K Sell
2,965
-24
-0.8% -$2.49K 0.02% 271
2016
Q1
$311K Sell
2,989
-46
-2% -$4.4K 0.02% 271
2015
Q4
$342K Buy
3,035
+82
+3% +$9.06K 0.02% 272
2015
Q3
$323K Sell
2,953
-131
-4% -$14K 0.02% 280
2015
Q2
$295K Sell
3,084
-323
-9% -$30.2K 0.02% 287
2015
Q1
$317K Buy
3,407
+89
+3% +$7.79K 0.02% 293
2014
Q4
$272K Buy
+3,318
New +$254K 0.02% 290
2014
Q1
Sell
-18,045
Closed -$1.15M 308
2013
Q4
$1.15M Buy
18,045
+11,327
+169% +$729K 0.08% 216
2013
Q3
$456K Sell
6,718
-1,352
-17% -$96.5K 0.04% 233
2013
Q2
$582K Buy
+8,070
New +$534K 0.06% 212

Other funds holding ICUI

Rice Hall James & Associates's ICUI Position: Q3 2019 in Review

Rice Hall James & Associates sold out of ICU Medical (ICUI) in Q3 2019, closing a stake of 72,417 shares — an estimated $18.2M sold.

Rice Hall James & Associates first reported a position in ICUI in Q2 2013 and held it in 14 quarters. The position peaked at $18.2M in Q2 2019. 260 funds tracked by Wall St. Rank hold ICUI as of Q3 2019.

  • Rice Hall James & Associates reported no remaining ICU Medical position as of Q3 2019 after selling out during the quarter.
  • Rice Hall James & Associates sold 72,417 ICU Medical shares in Q3 2019, an estimated $18.2M.
  • Rice Hall James & Associates first reported a position in ICU Medical in Q2 2013 and held it in 14 quarters.
  • Rice Hall James & Associates's ICU Medical position peaked at $18.2M in Q2 2019.
  • 260 funds tracked by Wall St. Rank held ICU Medical as of Q3 2019.

Based on Rice Hall James & Associates's 13F filing for Q3 2019, filed 30 Oct 2019.